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Purpose: Genotype testing for HIV-1 drug resistance is useful for selecting
antiretroviral drug regimens for patients experiencing therapeutic failure.
The aim of the present study is to monitor the resistance trend in treat-
ment-experienced patients to guide the antiretroviral therapy in southern
Taiwan.
Methods: A retrospective cohort study on HIV-1 drug resistance was con-
ducted in antiretroviral therapy -experienced HIV-1 einfected individuals
at Kaohsiung Veterans General Hospital from 2009 to 2014. Genotypic
drug resistance was determined by ViroSeqTM system. Risk factor for
drug resistance was analyzed by Chi-square or Fisher’s exact tests,
and non-categorical variables were compared using the Mann-Whitney U
test
Results: From 2009 to 2014, a total of 65 patients had tested for resis-
tance, of whom 87% were infected by MSM, and 13% were infected by het-
erosexual. The prevalence rate for syphilis infection was 45%, hepatitis A
18%, hepatitis B 8% and hepatitis C 3%. Subtype B HIV-1strains were found
in 86% of the individuals, subtype CRF01_AE in 11% and subtype C in 3%.
The resistance rates to any three classes of antiretroviral therapy (NRTI,
NNRTI and PI) were 94%. The prevalence rate for NRTI, NNRTI and PI resis-
tance was 72%, 77% and 9%, respectively. The most common NRTI resis-
tance associated mutation was M184V (65%) and L74V (17%).The most
common NNRTI resistance associated mutation was K103N (29%), Y181C
(29%) and V179D (20%). The most PI resistance associated mutation was
A71T (17%), A71V (12%) and L10I (8%). The presence of drug resistance
was associated with longer duration of current failing anti-retroviral ther-
apy (pZ0.036).Figure. Frequency of NRTI, NNRTI and PI-associated mutation (%).
Conclusions: Our findings showed a high rate of antiretroviral drug resis-
tance in patient failure to the first line anti-retroviral therapy in southern
Taiwan. This result could better guide us in the development of efficacious
and effective management plans and strategies for treatment failure
patients.PS 2-342
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Purpose: The aim of this study is to investigate the YMDD motif amplification
and sequencing for detection of HBV genotype and Lamivudine resistance
simultaneously.
Methods: The YMDD motif was amplified by polymerase chain reaction (PCR)
with specific primers and the products were sequenced. The sequence of
YMDD motif was analyzed by “The genotype” software of the NCBI
(http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi) for HBV
genotyping and detection of 3TC resistance (YMDD motif analysis). RFLP of
the S gene was also performed for HBV genotyping and comparison with
the results of YMDD motif analysis. HBV viral load was measured by the
COBAS TaqMan 48 Real-Time PCR System.
Results: A total of 90 HBsAg positive specimens with vial load >1000 IU/ml
were included for study. By YMDD motif analysis, 60 genotype (GT-) B
(66.7%), 29 GT-C (33.2%), and 1 GT-D (1.1%) were identified and these results
were 100% in accordance with the results obtained by RFLP (Figure). Eighty-
seven (96.7%) were YMDD wild-type, 2 (2.2%) were YVDD mutant, and 1
(1.1%) was YIDD mutant.
Conclusions: YMDD motif analysis is a simple and accurate method for simul-
taneous detection of HBV genotype and Lamivudine resistance.
